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Calculation Skills: Dyspepsia with unidentified cause 
Dyspepsia is defined by NICE (2014) as ‘a complex of upper gastrointestinal tract symptoms which 
are typically present for four or more weeks’. These symptoms typically include heartburn, nausea, 
vomiting, acid reflux and upper abdominal discomfort, with up to 40% of the UK population affected 
annually (NICE, 2014). A systematic review undertaken by Ford et al (2015) found a higher 
prevalence amongst active smokers, women and those using NSAIDs. 
Lifestyle factors should be considered as part of the management of dyspepsia, with strategies such 
as weight loss, stress reduction, reduction of alcohol intake, avoidance of potential trigger foods 
(such as coffee, fatty or spicy foods) and smoking cessation identified as having the potential to 
reduce symptoms (NICE, 2017). 
 
Question 1 
Michael is a 49 year old company director, who has presented with symptoms of dyspepsia. He is 
average weight, smokes 30 cigarettes per day, drinks one and a half bottles of red wine* per day and 
works on average, 60 hours per week without a lunch break. He is advised to reduce his alcohol 
intake, consider stress management techniques and is offered support with smoking cessation. At 
his follow-up appointment, Michael has reduced the number of cigarettes he smokes by 35%, 
reduced his alcohol intake to 14 units per week, and has ensured that he only works between 8am 
and 6pm Monday to Friday, taking a 1 hour lunch break. 
*Michael’s preferred red wine contains 10 units of alcohol per 750ml bottle. 
(i) How many cigarettes does Michael now smoke per week (rounded up or down to the 
nearest whole number)?  
(ii) By what percentage has he reduced his alcohol consumption (rounded to 1 decimal 
point)? 
(iii) How many bottles of wine is Michael now drinking? 
(iv) By what percentage has he reduced his work hours? 
 
Question 2 
In line with NICE (2017) guidelines, Michael is to be prescribed one of the proton pump inhibitors 
(PPI) identified in table 1, at full-dose for 1 month.  
Table 1: PPIs for dyspepsia of unidentified cause 
PPI Full dose  Cost for 28 pack of full-dose tablets 
Omeprazole 20 mg once a day £0.58 
Lansoprazole 30 mg once a day £0.57 
Pantoprazole 40 mg once a day £0.62 
Rabeprazole 20 mg once a day £0.99 
Esomeprazole 20 mg once a day £2.64 
 
  
(i) On the basis of the information in table 1, what is the average cost of treatment of 
dyspepsia with a PPI for 12 months, (assuming that the incidence of the drug being 
prescribed is the same for all five drugs)? Assume 28 tablets as one month’s supply. 
(ii) How much more expensive (as a %) is the most expensive treatment than the least 
expensive treatment? 
 
Question 3 
As Michael’s symptoms persisted, he was tested for Helicobacter pylori infection. The test results 
were positive and he is to be commenced on the following 7-day triple therapy regimen in line with 
NICE (2017) guidelines: 
 esomeprazole 20 mg twice-daily and  
 amoxicillin 1 g twice-daily and 
 clarithromycin 500 mg twice-daily  
Amoxicillin = £0.78 for 21 pack of 500mg capsules, clarithromycin = £1.95 for 14 pack of 500mg 
tablets. 
(i) Based on the price per tablets/capsule, what is the total cost of the seven day treatment 
(ii) Using metronidazole 400 mg twice-daily instead of clarithromycin 500 mg twice-daily 
would make the overall cost £0.49 more expensive. What is the price of one 400mg 
metronidazole tablet? 
Metronidazole costs £3.67 for 21 400mg tablets 
 
Answers 
Question 1 
(i) 30 ÷ 100 = 0.3 
0.3 x 65 = 19.5 
20 (rounded up to the nearest whole number) 
(ii) 1.5 bottles per day 
1.5 x 10 = 15 units per day 
15 x 7 = 105 units per week 
105 – 14 = 91 
(91 ÷ 105) x 100 = 86.7% (rounded to 1dp) 
(iii) 14 ÷ 10 = 1.4 bottles per week 
(iv) 10 x 5 = 50 hours per week 
minus lunch breaks = 50 – 5 = 45 
60 hrs – 45 hrs = 15 hrs 
15 ÷ 60 = 0.25 x 100 = 25% 
Question 2 
(i) 0.58 x 12 = 6.96 
0.57 x 12 = 6.84 
0.62 x 12 = 7.44 
0.99 x 12 = 11.88 
2.64 x 12 = 31.68 
(6.96 + 6.84 + 7.44 + 11.88 + 31.68) ÷ 5 = £12.96 
(ii) 2.64 ÷ 0.57 = 4.63 x 100 = 463% 
 
Question 3 
(i) 7 days esomeprazole (14 tablets) = 2.64 ÷ 2 = £1.32 
7 days amoxicillin (28 capsules) = 0.78 ÷ 3 = 0.26 x 4 = £1.04 
7 days clarithromycin (14 tablets) = £1.95 
1.32 + 1.04 + 1.95 = £4.31 
(ii) Overall cost of new triple therapy (with metronidazole instead of clarithromycin) has 
increased by £0.49. As the only drug changed is clarithromycin, this increased cost applies to the 
replacement of that drug. Therefore, cost of 7 days treatment with metronidazole = £1.95 + 
£0.49 = £2.44 
      Cost of 1 metronidazole tablet = £2.44 ÷ 14 (tablets) = £0.17 
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